Winston Kung
Director of Finance/CFO presso ARRIVENT BIOPHARMA, INC.
Patrimonio netto: 18 020 $ in data 31/03/2024
Profilo
Winston Kung is an Independent Director and Chief Financial Officer & Treasurer at Janux Therapeutics, Inc. and Arrivent BioPharma, Inc. respectively.
He previously worked as a Director-Global Healthcare at Citigroup, Inc., Principal at Amgen, Inc., Vice President-Global Mergers & Acquisitions at Lehman Brothers, Inc., VP-Business Development & Global Alliances at Celgene Corp., Director at Alliqua BioMedical, Inc., Chief Business Officer at Celgene Cellular Therapeutics, and Chief Operating & Financial Officer at PMV Pharmaceuticals, Inc. Mr. Kung received his undergraduate degree from Brown University and his MBA from Harvard Business School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 12/05/2023 | 10 600 ( 0.02% ) | 18 020 $ | 31/03/2024 | |
JANUX THERAPEUTICS, INC.
-.--% | 14/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Winston Kung
| Società | Posizione | Inizio |
|---|---|---|
| JANUX THERAPEUTICS, INC. | Director/Board Member | 22/09/2022 |
| ARRIVENT BIOPHARMA, INC. | Director of Finance/CFO | 01/01/2024 |
Precedenti posizioni note di Winston Kung
| Società | Posizione | Fine |
|---|---|---|
| PMV PHARMACEUTICALS, INC. | Director of Finance/CFO | 04/01/2024 |
Alliqua BioMedical, Inc.
 Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | Director/Board Member | 24/11/2017 |
| CELGENE | Corporate Officer/Principal | 01/11/2017 |
Celgene Cellular Therapeutics
 Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene Cellular Therapeutics develops human pharmaceuticals. The private company is based in Warren, NJ. The company was founded by Robert Joseph Hariri Gordon. | Corporate Officer/Principal | 01/02/2015 |
| CITIGROUP INC. | Corporate Officer/Principal | 01/04/2013 |
Formazione di Winston Kung
| Brown University | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| AMGEN INC. | Health Technology |
| CITIGROUP INC. | Finance |
| PMV PHARMACEUTICALS, INC. | Commercial Services |
| JANUX THERAPEUTICS, INC. | Health Technology |
| ARRIVENT BIOPHARMA, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues. | Finance |
Aitia, Inc.
 Aitia, Inc. Miscellaneous Commercial ServicesCommercial Services GNS Healthcare, Inc. provides analytics solutions for the healthcare industry. The firm offers solutions for electronic health records, claims, clinical and incentive programs, reward, product development solutions for biopharmaceutical, diagnostic, consumer product, and medical device companies and publications, conference abstracts, and presentations. The company was founded by Colin Hill and Iya Khalil in 2000 and is headquartered in Cambridge, MA. | Commercial Services |
Celgene Cellular Therapeutics
Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene Cellular Therapeutics develops human pharmaceuticals. The private company is based in Warren, NJ. The company was founded by Robert Joseph Hariri Gordon. | Health Technology |
Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | Health Technology |
- Borsa valori
- Insiders
- Winston Kung
